Steroid-refractory immune thrombocytopenia in the era of the new thrombomimetic drugs: is there still a role for rituximab?

Detalles Bibliográficos
Autores principales: Palombi, Massimiliano, Scaramucci, Laura, Giovannini, Marco, Trawinska, Malgorzata Monika, Niscola, Pasquale, de Fabritiis, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2016
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828534/
https://www.ncbi.nlm.nih.gov/pubmed/27104196
http://dx.doi.org/10.5045/br.2016.51.1.66
_version_ 1782426597303779328
author Palombi, Massimiliano
Scaramucci, Laura
Giovannini, Marco
Trawinska, Malgorzata Monika
Niscola, Pasquale
de Fabritiis, Paolo
author_facet Palombi, Massimiliano
Scaramucci, Laura
Giovannini, Marco
Trawinska, Malgorzata Monika
Niscola, Pasquale
de Fabritiis, Paolo
author_sort Palombi, Massimiliano
collection PubMed
description
format Online
Article
Text
id pubmed-4828534
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
record_format MEDLINE/PubMed
spelling pubmed-48285342016-04-21 Steroid-refractory immune thrombocytopenia in the era of the new thrombomimetic drugs: is there still a role for rituximab? Palombi, Massimiliano Scaramucci, Laura Giovannini, Marco Trawinska, Malgorzata Monika Niscola, Pasquale de Fabritiis, Paolo Blood Res Letter to the Editor Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2016-03 2016-03-25 /pmc/articles/PMC4828534/ /pubmed/27104196 http://dx.doi.org/10.5045/br.2016.51.1.66 Text en © 2016 Korean Society of Hematology http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Palombi, Massimiliano
Scaramucci, Laura
Giovannini, Marco
Trawinska, Malgorzata Monika
Niscola, Pasquale
de Fabritiis, Paolo
Steroid-refractory immune thrombocytopenia in the era of the new thrombomimetic drugs: is there still a role for rituximab?
title Steroid-refractory immune thrombocytopenia in the era of the new thrombomimetic drugs: is there still a role for rituximab?
title_full Steroid-refractory immune thrombocytopenia in the era of the new thrombomimetic drugs: is there still a role for rituximab?
title_fullStr Steroid-refractory immune thrombocytopenia in the era of the new thrombomimetic drugs: is there still a role for rituximab?
title_full_unstemmed Steroid-refractory immune thrombocytopenia in the era of the new thrombomimetic drugs: is there still a role for rituximab?
title_short Steroid-refractory immune thrombocytopenia in the era of the new thrombomimetic drugs: is there still a role for rituximab?
title_sort steroid-refractory immune thrombocytopenia in the era of the new thrombomimetic drugs: is there still a role for rituximab?
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828534/
https://www.ncbi.nlm.nih.gov/pubmed/27104196
http://dx.doi.org/10.5045/br.2016.51.1.66
work_keys_str_mv AT palombimassimiliano steroidrefractoryimmunethrombocytopeniaintheeraofthenewthrombomimeticdrugsistherestillaroleforrituximab
AT scaramuccilaura steroidrefractoryimmunethrombocytopeniaintheeraofthenewthrombomimeticdrugsistherestillaroleforrituximab
AT giovanninimarco steroidrefractoryimmunethrombocytopeniaintheeraofthenewthrombomimeticdrugsistherestillaroleforrituximab
AT trawinskamalgorzatamonika steroidrefractoryimmunethrombocytopeniaintheeraofthenewthrombomimeticdrugsistherestillaroleforrituximab
AT niscolapasquale steroidrefractoryimmunethrombocytopeniaintheeraofthenewthrombomimeticdrugsistherestillaroleforrituximab
AT defabritiispaolo steroidrefractoryimmunethrombocytopeniaintheeraofthenewthrombomimeticdrugsistherestillaroleforrituximab

Ejemplares similares